University of Utah

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel (2023) Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, Wang Q, et al. Journal article Highlights From the Annual Meeting of the American Epilepsy Society 2022 (2023) Valencia I, Alexander AL, Andrade DM, Arevalo-Astrada M, Rubiños C, Auer N, Bainbridge JL, et al. Journal article Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy (2023) Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, Zanoni F, Liu L, Mladkova N, Khan A, et al. Journal article A study on the accuracy of polynomial fitting for direct computation of material lengths from projection data in dual energy CT (2023) Haase V, Stierstorfer K, Maier A, Noo F Conference contribution Community recommendations for geochemical data, services and analytical capabilities in the 21st century (2023) Klöcking M, Wyborn L, Lehnert KA, Ware B, Prent AM, Profeta L, Kohlmann F, et al. Journal article, Review article International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action (2023) Cheung AK, Whelton PK, Muntner P, Schutte AE, Moran AE, Williams B, Sarafidis P, et al. Journal article Detailed Analysis of the TeV γ-Ray Sources 3HWC J1928+178, 3HWC J1930+188, and the New Source HAWC J1932+192 (2023) Albert A, Alfaro R, Alvarez C, Arteaga-Velazquez JC, Rojas DA, Solares HAA, Babu R, et al. Journal article γ-Ray Emission from Classical Nova V392 Per: Measurements from Fermi and HAWC (2022) Albert A, Alfaro R, Alvarez C, Arteaga-Velázquez JC, Rojas DA, Solares HA, Babu R, et al. Journal article Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (Breast Cancer Research, (2022), 24, 1, (69), 10.1186/s13058-022-01567-3) (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BA, Becher H, Blomqvist C, et al. Journal article, Erratum PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BAM, Becher H, Blomqvist C, et al. Journal article